Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections.

International Journal of Antimicrobial Agents
Michael P VeveMahmoud A Shorman

Abstract

To assess the efficacy and safety of dalbavancin compared to standard-of-care (SOC) or vancomycin and daptomycin in invasive infections due to suspected or confirmed Gram-positive organisms. Retrospective cohort of adults who received dalbavancin or SOC on discharge or as an outpatient from 12/2016 to 11/2019. Indications were osteoarticular infection (OAI), infective endocarditis (IE), or other bloodstream infection (BSI). Primary endpoint was 90-day infection-related readmission (IRR); secondary endpoints included time-to-IRR, frequency of adverse drug events (ADEs), and all-cause readmission and mortality. 215 patients were included: 70 (33%) receiving dalbavancin, and 145 (67%) receiving SOC. Indications were OAI (47%), IE (27%), and other BSI (26%). OAI was more common in patients on dalbavancin compared with those receiving SOC (70% vs. 37%, P<0.001). Dalbavancin patients had shorter median (interquartile range [IQR]) length of stay (LOS) prior to drug initiation compared with those receiving SOC (10 [7-17] vs. 13 [9-19], P=0.021). IRR incidence was 17% for dalbavancin patients and 28% for SOC patients. Dalbavancin use was independently associated with lower IRR (adjusted odds ratio [adjOR], 0.10; 95% confidence interval ...Continue Reading

References

Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J S LiG R Corey
Feb 26, 2004·Antimicrobial Agents and Chemotherapy·Anton LeightonEllen Kelly
Jan 7, 2015·Antimicrobial Agents and Chemotherapy·Michael W DunneJames Baldassarre
Oct 30, 2015·The Journal of Antimicrobial Chemotherapy·Nabin K ShresthaSusan J Rehm
Aug 18, 2016·The Journal of Antimicrobial Chemotherapy·Vasilios AthansSusan L Davis
Aug 8, 2017·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·B J WerthS M Butler-Wu
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara C KellerSara E Cosgrove
Nov 29, 2017·International Journal of Antimicrobial Agents·Emilio BouzaUNKNOWN DALBUSE Study Group (Dalbavancina: Estudio de su uso clinico en España)
Apr 17, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Selma TobudicFlorian Thalhammer
Nov 7, 2018·Diagnostic Microbiology and Infectious Disease·Thamer A AlmangourKeith S Kaye
Nov 14, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anne H NorrisCraig A Umscheid
Feb 23, 2019·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·S WunschI Zollner-Schwetz
Mar 7, 2019·Open Forum Infectious Diseases·Chloe Bryson-CahnShireesha Dhanireddy
Mar 13, 2019·Antimicrobial Agents and Chemotherapy·L MorataA Soriano
Jul 20, 2019·The Journal of Antimicrobial Chemotherapy·Taylor MorrisetteMartin Krsak
Aug 10, 2019·International Journal of Antimicrobial Agents·Amber C StreifelJames S Lewis
Aug 11, 2019·International Journal of Antimicrobial Agents·Aurélien DinhUNKNOWN Dalbavancin French Study Group
Oct 21, 2019·Annals of Clinical Microbiology and Antimicrobials·Carmen Hidalgo-TenorioJuan Pasquau
Sep 3, 2020·The Journal of Infectious Diseases·Grace E CookseyMichael P Veve

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Antimicrobial Agents
Emilio BouzaDALBUSE Study Group (Dalbavancina: Estudio de su uso clinico en España)
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Selma Tobudic, Florian Thalhammer
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society
Thamer A AlmangourAbdullah A Alhifany
© 2021 Meta ULC. All rights reserved